| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/11/2002 | EP1238678A1 Enzyme-activated cytostatic conjugates with integrin ligands |
| 09/11/2002 | EP1238677A2 Parenteral fat emulsions comprising edetate as preservative |
| 09/11/2002 | EP1238676A1 Combination of a serotonin reuptake inhibitor and an atypical antipsychotic for use in depression, obsessive compulsive disorder and psychosis |
| 09/11/2002 | EP1238675A1 Recombinant gelatin-like proteins for use as plasma expanders |
| 09/11/2002 | EP1238670A1 Composition and method for treating and preventing cardiovascular disease and hypertension. |
| 09/11/2002 | EP1238669A2 Neutrophil function inhibitors which contain glucosamine |
| 09/11/2002 | EP1238668A1 Use of thiolutin dioxide and its derivatives in the manufacture of a medicament for the treatment of CNS disorders and a process for the preparation thereof |
| 09/11/2002 | EP1238667A2 Use of benzothiophenes for treatment of hypercholesterolaemia |
| 09/11/2002 | EP1238666A2 Use of xanthenone-4-acetic acid in the manufacture of a medicament in the treatment of hyperproliferative disorders |
| 09/11/2002 | EP1238665A1 Method for dispensing s-adenosyl-methionine in a micro fine powdered form by inhalation |
| 09/11/2002 | EP1238655A1 Composition containing a derivative of polyamino acids, and use of this compound to combat skin wrinkles |
| 09/11/2002 | EP1238654A2 Composition for external application containing a diamide derivative |
| 09/11/2002 | EP1238652A1 Compositions for peeling |
| 09/11/2002 | EP1238650A2 Antimicrobial flavor and oral care composition containing the same |
| 09/11/2002 | EP1238647A1 Use of polyaminoacid derivatives as hydrating agents and cosmetic and pharmaceutical compositions containing them |
| 09/11/2002 | EP1238644A1 Stabilizers for l-ascorbic acid-2-sodium phosphate |
| 09/11/2002 | EP1238281A2 Cancer associated antigens and uses therefor |
| 09/11/2002 | EP1238159A1 Tissue products containing antiviral agents which are mild to the skin |
| 09/11/2002 | EP1238082A2 Ifn-alpha homologues |
| 09/11/2002 | EP1238080A2 Bcl-g polypeptides, encoding nucleic acids and methods of use |
| 09/11/2002 | EP1238077A1 Tnfr/opg-like molecules and uses thereof |
| 09/11/2002 | EP1238072A2 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes |
| 09/11/2002 | EP1238071A2 Uncharged antisense oligonucleotides targeted to bacterial 16s and 23s rrnas and their uses |
| 09/11/2002 | EP1238070A2 Therapeutically useful synthetic oligonucleotides |
| 09/11/2002 | EP1238066A2 Masp-3, a complement-fixing enzyme, and uses for it |
| 09/11/2002 | EP1238016A1 Substituted phthalocyanines and their precursors |
| 09/11/2002 | EP1237936A1 Molecularly inprinted polymers produced by template polymerisation |
| 09/11/2002 | EP1237919A1 Interferon-alpha induced gene |
| 09/11/2002 | EP1237916A2 Ing2, an iaps associated cell cycle protein, compositions and methods of use |
| 09/11/2002 | EP1237914A1 Methods for improving secondary metabolite production in fungi |
| 09/11/2002 | EP1237904A2 14,15-beta-methylene substituted androgens |
| 09/11/2002 | EP1237903A1 11-beta-phenylestradiene derivatives with fluoroalkyl groups in the aromatic side chain, production thereof and pharmaceutical compositions containing these compounds |
| 09/11/2002 | EP1237902A1 Halogenated sulphamate-, phosphonate-, thiophosphonate-, sulphonate- and sulphonamide- compounds as inhibitors of steroid sulphatase |
| 09/11/2002 | EP1237901A1 28 human secreted proteins |
| 09/11/2002 | EP1237898A2 N?6 heterocyclic 8-modified adenosine derivatives |
| 09/11/2002 | EP1237897A2 Antithrombotic compound |
| 09/11/2002 | EP1237892A2 Method for producing epinastine hydrochloride in the high-melting crystal modification |
| 09/11/2002 | EP1237891A1 Heterocyclic dihydropyrimidines as potassium channel inhibitors |
| 09/11/2002 | EP1237890A1 Synthesis and methods of use of 9-substituted guanine derivatives |
| 09/11/2002 | EP1237889A1 Antibiotic sultam and sultone derived oxazolidinones |
| 09/11/2002 | EP1237888A2 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 09/11/2002 | EP1237887A1 9-(piperazinylalkyl)carbazoles as bax-modulators |
| 09/11/2002 | EP1237886A1 Heterocyclic derivatives |
| 09/11/2002 | EP1237880A2 Pyrazine based inhibitors of glycogen synthase kinase 3 |
| 09/11/2002 | EP1237878A2 4-pyrimidinyl-n-acyl-l-phenylalanines |
| 09/11/2002 | EP1237877A2 Carboxamide-substituted benzimidazol derivatives, methods for the production thereof and their use as medicaments |
| 09/11/2002 | EP1237876A1 N-(1-phenylethyl)-5-phenyl-imidazole-2-amine compounds, their compositions and uses |
| 09/11/2002 | EP1237875A1 Substituted imidazole neuropeptide y y5 receptor antagonists |
| 09/11/2002 | EP1237874A2 Selective neurokinin antagonists |
| 09/11/2002 | EP1237873A2 Control of arthropods in animals |
| 09/11/2002 | EP1237869A1 Compounds, compositions, and methods for stimulating neuronal growth and elongation |
| 09/11/2002 | EP1237866A1 Amycomycin, a process for its production and its use as a pharmaceutical |
| 09/11/2002 | EP1237862A1 Succinate compounds, compositions and methods of use and preparation |
| 09/11/2002 | EP1237859A2 Use of bis-sulfonamides for producing medicaments used for preventing or treating hyperlipidaemia |
| 09/11/2002 | EP1237857A1 New phenalkyloxy-phenyl derivatives |
| 09/11/2002 | EP1237856A1 New tri-substituted phenyl derivatives and analogues |
| 09/11/2002 | EP1237855A1 Crystalline form of (s)-2 ethoxy-3- 4-(2- 4-methanesulfonyloxyphenyl ethoxy) phenyl] propanoic acid |
| 09/11/2002 | EP1237854A1 Comminuted form of (s)-2-ethoxy -3- 4-(2- 4-methanesulfonyloxyphenyl ethoxy) phenyl] propanoic acid |
| 09/11/2002 | EP1237851A2 SALTS OF i Cis /i -4-CYANO-4- 3-(CYCLOPENTYLOXY)-4-METHOXYPHENYL]CYCLOHEXANE-1-CARBOXYLIC ACID |
| 09/11/2002 | EP1237849A1 Activators of soluble guanylate cyclase |
| 09/11/2002 | EP1237845A1 Aminobenzophenones as inhibitors of il-1beta and tnf-alpha |
| 09/11/2002 | EP1237580A2 Amphiphilic polymers and polypeptide conjugates comprising same |
| 09/11/2002 | EP1237579A2 Surfactants as malarial chloroquine resistance reversal agents |
| 09/11/2002 | EP1237577A2 Transmucosal composition containing a phosphodiesterase inhibitor for the treatment of erectile dysfunction |
| 09/11/2002 | EP1237576A1 Antiviral agent for use in treatment of cancer |
| 09/11/2002 | EP1237569A1 An additive for an animal feed |
| 09/11/2002 | EP1237563A1 Nutritional composition, methods of producing said composition and methods of using said composition |
| 09/11/2002 | EP1237562A2 Dna polymerase inhibitors, mikanolide and dihydromikanolide |
| 09/11/2002 | EP1237559A1 Pharmaceutical combinations |
| 09/11/2002 | EP1237558A1 Novel helicobacter pylori-binding substances and use thereof |
| 09/11/2002 | EP1237557A1 Galenical preparations of dapsone and related sulphones, and method of therapeutic and preventative treatment of disease |
| 09/11/2002 | EP1237556A2 Pharmaceutical implant containing immediate-release and sustained-release components and method of administration |
| 09/11/2002 | EP1237555A2 Implant composition containing melengestrol acetate and trenbolone acetate |
| 09/11/2002 | EP1237554A2 Use of sodium channel antagonists for the treatment of diseases related to apoptosis |
| 09/11/2002 | EP1237553A2 The combination of a serotonin reuptake inhibitor and a 5-ht 2c? antagonist, inverse agonist or partial agonist |
| 09/11/2002 | EP1237552A1 Combination of an ergoline and riluzole for preventing and treating motor neuron diseases |
| 09/11/2002 | EP1237551A1 Pharmaceutical formulations containing zolmitriptan |
| 09/11/2002 | EP1237550A2 Methods for treating cell death diseases and inflammation |
| 09/11/2002 | EP1237549A1 Lipoxin a4 and its analogs for the treatment of dry eye |
| 09/11/2002 | EP1237548A1 Il-8 receptor antagonists |
| 09/11/2002 | EP1237547A2 Compounds for inhibiting diseases and preparing cells for transplantation |
| 09/11/2002 | EP1237546A2 Dihydroorotate dehydrogenase inhibitors for the treatment of viral-mediated diseases |
| 09/11/2002 | EP1237545A2 Use of g(a)-linolenic acid metabolites in the manufacture of a medicament for the treatment or prevention of cancer |
| 09/11/2002 | EP1237544A1 System and method for extended delivery of a therapeutic agent with its receptor loading dose |
| 09/11/2002 | EP1237543A1 Effervescent histamine h2 antagonist composition |
| 09/11/2002 | EP1237540A2 Pharmaceutical gel and aerosol formulations and methods to administer the same to skin and mucosal surfaces |
| 09/11/2002 | EP1237539A1 Oral solution containing galanthamine and a sweetening agent |
| 09/11/2002 | EP1237538A2 An improved pharmaceutical composition for treating male erectile dysfunction |
| 09/11/2002 | EP1237537A1 Composition in the form of a gel for receiving an active ingredient in a solution or suspension, especially for application on a mucous membrane and method of production thereof |
| 09/11/2002 | EP1237536A1 The use of fluorescent whitening agents |
| 09/11/2002 | EP1237532A2 Ultraviolet radiation absorbing waxes useful in cosmetic compositions |
| 09/11/2002 | EP1237524A2 Analogs of galanthamine and lycoramine as modulators of nicotinic receptors |
| 09/11/2002 | EP1237424A1 Composition for improving the proliferative response during adaptation of the gastrointestinal tract and use in short bowel syndrome |
| 09/11/2002 | EP1237420A2 Reduced calorie fat compositions |
| 09/11/2002 | EP1207908A4 Method of treating body insect infestation |
| 09/11/2002 | EP1133500B1 Organophosphorous compounds and the use thereof |
| 09/11/2002 | EP1079838B1 Edelfosin for the treatment of brain tumours |
| 09/11/2002 | EP1067936B1 Formulation of fast-dissolving efavirenz capsules or tablets using super-disintegrants |
| 09/11/2002 | EP1047409B1 Tts containing an antioxidant |
| 09/11/2002 | EP1017406B1 Bovine excretion extracts having anticancer and anti-inflammatory activity and process for preparing the same |